Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page adds a recruitment status note indicating that no participants are currently being sought and introduces new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header formatting and updates the page revision from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-14T06:18:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a software update. This change does not affect the study details or other user-visible information.
    Difference
    0.0%
    Check dated 2026-06-07T01:45:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page shows a new Revision label, updating from v3.5.3 to v3.5.4, indicating a small build-level update.
    Difference
    0.0%
    Check dated 2026-05-16T10:09:13.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 33305 was removed. Taoyuan, Taiwan, 33305 was added in the Locations list, updating the Taiwan site address to reflect current administrative naming.
    Difference
    0.0%
    Check dated 2026-05-01T21:58:06.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page’s displayed revision/version label from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T17:07:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a backend version update and does not modify study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-04-17T14:09:36.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.